The EGF receptor as central transducer of heterologous signalling systems.
暂无分享,去创建一个
[1] R. Lefkowitz,et al. Regulation of tyrosine kinase cascades by G-protein-coupled receptors. , 1999, Current opinion in cell biology.
[2] A. Ullrich,et al. Epidermal growth factor receptors: critical mediators of multiple receptor pathways. , 1999, Current opinion in cell biology.
[3] M. Maa,et al. c-Src-mediated Phosphorylation of the Epidermal Growth Factor Receptor on Tyr845 and Tyr1101 Is Associated with Modulation of Receptor Function* , 1999, The Journal of Biological Chemistry.
[4] S. Parsons,et al. Mechanism of biological synergy between cellular Src and epidermal growth factor receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[5] M. Caron,et al. Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. , 1999, Science.
[6] G. Plowman,et al. The discovery and validation of new drug targets in cancer. , 1998, Current opinion in biotechnology.
[7] L. Silengo,et al. Integrins induce activation of EGF receptor: role in MAP kinase induction and adhesion‐dependent cell survival , 1998, The EMBO journal.
[8] K. Barrett,et al. Carbachol stimulates transactivation of epidermal growth factor receptor and mitogen-activated protein kinase in T84 cells. Implications for carbachol-stimulated chloride secretion. , 1998, The Journal of biological chemistry.
[9] J. Gutkind,et al. Cell growth control by G protein-coupled receptors: from signal transduction to signal integration , 1998, Oncogene.
[10] N. Dhanasekaran,et al. Regulation of cell proliferation by G proteins , 1998, Oncogene.
[11] S. Soltoff. Related Adhesion Focal Tyrosine Kinase and the Epidermal Growth Factor Receptor Mediate the Stimulation of Mitogen-activated Protein Kinase by the G-protein-coupled P2Y2 Receptor , 1998, The Journal of Biological Chemistry.
[12] D Tripathy,et al. Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] T. Gudermann,et al. Ligand-independent activation of platelet-derived growth factor receptor is a necessary intermediate in lysophosphatidic, acid-stimulated mitogenic activity in L cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[14] S. Rhee,et al. Reversible Inactivation of Protein-tyrosine Phosphatase 1B in A431 Cells Stimulated with Epidermal Growth Factor* , 1998, The Journal of Biological Chemistry.
[15] J. Turkson,et al. Role of Tyrosine Kinase Activity of Epidermal Growth Factor Receptor in the Lysophosphatidic Acid-stimulated Mitogen-activated Protein Kinase Pathway* , 1998, The Journal of Biological Chemistry.
[16] H. Kung,et al. Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells , 1998, Nature.
[17] L. Graves,et al. Angiotensin II stimulates ERK via two pathways in epithelial cells: protein kinase C suppresses a G–protein coupled receptor–EGF receptor transactivation pathway , 1998, The EMBO journal.
[18] H. Kawakatsu,et al. Calcium-dependent Epidermal Growth Factor Receptor Transactivation Mediates the Angiotensin II-induced Mitogen-activated Protein Kinase Activation in Vascular Smooth Muscle Cells* , 1998, The Journal of Biological Chemistry.
[19] S. Vaingankar,et al. Thrombin Aivation of the 9E3/CEF4 Chemokine Involves Tyrosine Kinases Including c-src and the Epidermal Growth Factor Receptor* , 1998, The Journal of Biological Chemistry.
[20] G. Schultz,et al. The G-protein G13 but Not G12 Mediates Signaling from Lysophosphatidic Acid Receptor via Epidermal Growth Factor Receptor to Rho* , 1998, The Journal of Biological Chemistry.
[21] D. Stern,et al. Specificity within the EGF family/ErbB receptor family signaling network , 1998, BioEssays : news and reviews in molecular, cellular and developmental biology.
[22] R. Lefkowitz,et al. G Protein-coupled Receptors Mediate Two Functionally Distinct Pathways of Tyrosine Phosphorylation in Rat 1a Fibroblasts , 1997, The Journal of Biological Chemistry.
[23] A. Ullrich,et al. Signal characteristics of G protein‐transactivated EGF receptor , 1997, The EMBO journal.
[24] Kohjiro Ueki,et al. Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone , 1997, Nature.
[25] A. Ullrich,et al. Critical Role of Calcium- dependent Epidermal Growth Factor Receptor Transactivation in PC12 Cell Membrane Depolarization and Bradykinin Signaling* , 1997, The Journal of Biological Chemistry.
[26] S. Hubbard. Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog , 1997, The EMBO journal.
[27] E. Peralta,et al. The m1 muscarinic acetylcholine receptor transactivates the EGF receptor to modulate ion channel activity , 1997, The EMBO journal.
[28] R. Lefkowitz,et al. Ras-dependent Mitogen-activated Protein Kinase Activation by G Protein-coupled Receptors , 1997, The Journal of Biological Chemistry.
[29] N. Hynes,et al. ErbB‐2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling , 1997, The EMBO journal.
[30] H. Bourne,et al. How receptors talk to trimeric G proteins. , 1997, Current opinion in cell biology.
[31] R. Lefkowitz,et al. Gbetagamma subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-mediated Ras activation. , 1997, The Journal of biological chemistry.
[32] A. Wong,et al. Subsets of Epidermal Growth Factor Receptors during Activation and Endocytosis* , 1997, The Journal of Biological Chemistry.
[33] A. Ullrich,et al. Novel mechanisms of RTK signal generation. , 1997, Current opinion in genetics & development.
[34] S. Lev,et al. A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation , 1996, Nature.
[35] Y. Yarden,et al. A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor , 1996, Molecular and cellular biology.
[36] A. Ullrich,et al. Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents. , 1996, The EMBO journal.
[37] E. Dmitrovsky,et al. The epidermal growth factor receptor and its ligands as therapeutic targets in human tumors. , 1996, Cytokine & growth factor reviews.
[38] P G Pelicci,et al. Not all Shc's roads lead to Ras. , 1996, Trends in biochemical sciences.
[39] M. Kitajima,et al. Further evidence for prognostic significance of epidermal growth factor receptor gene amplification in patients with esophageal squamous cell carcinoma. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[40] A. Levitzki. Targeting signal transduction for disease therapy. , 1996, Current opinion in cell biology.
[41] E. Adamson,et al. UV activates growth factor receptors via reactive oxygen intermediates , 1996, The Journal of cell biology.
[42] J. Pouysségur,et al. Shc adaptor proteins are key transducers of mitogenic signaling mediated by the G protein‐coupled thrombin receptor. , 1996, The EMBO journal.
[43] A. Levitzki,et al. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor , 1996, Nature.
[44] A. Ullrich,et al. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors , 1996, Nature.
[45] M. Greenberg,et al. Stimulation of growth factor receptor signal transduction by activation of voltage-sensitive calcium channels. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[46] K. Rubin,et al. Stimulation of beta1 integrins on fibroblasts induces PDGF independent tyrosine phosphorylation of PDGF beta-receptors , 1996, The Journal of cell biology.
[47] M. Greenberg,et al. Ca2+-Dependent Routes to Ras: Mechanisms for Neuronal Survival, Differentiation, and Plasticity? , 1996, Neuron.
[48] Y. Yarden,et al. ErbB‐2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer. , 1996, The EMBO journal.
[49] L. Dorssers,et al. Expression of estrogen, progesterone and epidermal growth factor receptors in primary and metastatic breast cancer , 1995, International journal of cancer.
[50] N. Lydon,et al. Src Phosphorylation of the Epidermal Growth Factor Receptor at Novel Sites Mediates Receptor Interaction with Src and P85α (*) , 1995, The Journal of Biological Chemistry.
[51] A. Levitzki,et al. Tyrosine kinase inhibition: an approach to drug development. , 1995, Science.
[52] J. Baselga,et al. Cooperative antiproliferative effects of 8-chloro-cyclic AMP and 528 anti-epidermal growth factor receptor monoclonal antibody on human cancer cells. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.
[53] F. M. Huennekens. Tumor targeting: activation of prodrugs by enzyme-monoclonal antibody conjugates. , 1994, Trends in biotechnology.
[54] P. Seeburg,et al. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells , 1984, Nature.
[55] A. Ullrich,et al. Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences , 1984, Nature.
[56] P. Carter,et al. Anti-p185HER2 monoclonal antibodies: biological properties and potential for immunotherapy. , 1992, Cancer treatment and research.
[57] J. Schlessinger,et al. Ligand-independent tyrosine phosphorylation of EGF receptor and the erbB-2/neu proto-oncogene product is induced by hyperosmotic shock. , 1989, Oncogene.